Use of vitamin D with anti-osteoporotic drugs: are available clinical trials telling us the whole story?

AbstractThere is a strong rationale for using vitamin D in combination with anti-osteoporotic drugs. Still, available trials do not give clear indications in this setting, presenting a suboptimal and heavily inhomogeneous experimental design. Health authorities should revise requirements for using vitamin D in anti-osteoporotic drug trials to maximise their effect and produce reliable indications for clinical practice in this setting.
Source: Endocrine - Category: Endocrinology Source Type: research